How can sequential therapy be used in castration-resistant prostate cancer?
by Gerald Mickisch
Clinical implications of CTCs in prostate cancer – are they the best thing to measure?
by Susanne Osanto
Advanced prostate cancer treatment – if, when and what?
by Axel Merseburger
Results of KEYNOTE-024 trial of pembrolizumab in NSCLC
by Martin Reck
Major changes in treatments for patients with metastatic squamous cell lung cancer
by Johan Vansteenkiste